Document is current
Any future updates will be listed below
-
Authors
Hubben, Anne https://orcid.org/0000-0001-7382-2222
Dima, Danai https://orcid.org/0000-0002-3587-7975
Atieh, Tahani
Chaulagain, Chakra
Faiman, Beth
Ferraro, Christina
Mazzoni, Sandra https://orcid.org/0000-0001-7548-0705
Williams, Louis
Samaras, Christy
Valent, Jason
Sauter, Craig
Anwer, Faiz https://orcid.org/0000-0001-6914-7439
Khouri, Jack
- License Information
-
More Information
Article History
Received: 18 November 2022
Revised: 7 February 2023
Accepted: 14 February 2023
First Online: 24 February 2023
Competing interests
: Anne Hubben, Danai Dima, Tahani Atieh, Lisa Rybicki, Chakra Chaulagain, Beth Faiman, Christy J. Samaras, Sandra Mazzoni, Louis Williams, and Jack Khouri have no conflict of interest to declare. Faiz Anwer: Bristol Myers Squibb (Consultancy, Research Funding, and Speakers Bureau), Janssen (Consultancy), Allogene Therapeutics (Research Funding). Jason Valent: Alexion, AstraZeneca Rare Disease (Research Funding). Craig Sauter<sup>:</sup> Genzyme/Sanofi (Other: PI), Kite Pharma Inc (Consultancy), CSL Behring (Consultancy), Ono Pharmaceuticals (Consultancy), Karyopharm Therapeutics Inc. (Consultancy), Gamida Cell (Consultancy), Bristol Myers Squibb (Other: PI), Precision Biosciences (Other: PI).
